TrialHuman vaccines & immunotherapeutics2025

Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.

Siyue Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.